(11R,15R,17R)-2,4,5,9-tetramethoxy-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1,3(8),4,6,9-pentaen-13-one

C20H22O7 — CID 56590221

IUPAC(11R,15R,17R)-2,4,5,9-tetramethoxy-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1,3(8),4,6,9-pentaen-13-one
SMILESCOc1ccc2c(OC)c3c(c(OC)c2c1OC)[C@@H](C)O[C@@H]1CC(=O)O[C@H]31
InChIInChI=1S/C20H22O7/c1-9-14-16(19-12(26-9)8-13(21)27-19)17(23-3)10-6-7-11(22-2)18(24-4)15(10)20(14)25-5/h6-7,9,12,19H,8H2,1-5H3/t9-,12-,19+/m1/s1
InChIKeyREMXYFUORROQDG-VVSLUIPWSA-N
MW374.39 g/mol
LogP3.32
Rot. Bonds4

About (11R,15R,17R)-2,4,5,9-tetramethoxy-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1,3(8),4,6,9-pentaen-13-one

(11R,15R,17R)-2,4,5,9-tetramethoxy-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1,3(8),4,6,9-pentaen-13-one (PubChem CID 56590221) has the molecular formula C20H22O7 and a molecular weight of 374.39 g/mol. Its IUPAC name is (11R,15R,17R)-2,4,5,9-tetramethoxy-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1,3(8),4,6,9-pentaen-13-one.

Molecular Properties

Compound Name(11R,15R,17R)-2,4,5,9-tetramethoxy-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1,3(8),4,6,9-pentaen-13-one
PubChem CID56590221
Molecular FormulaC20H22O7
Molecular Weight374.39 g/mol
Exact Mass374.14
IUPAC Name(11R,15R,17R)-2,4,5,9-tetramethoxy-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1,3(8),4,6,9-pentaen-13-one
SMILESCOc1ccc2c(OC)c3c(c(OC)c2c1OC)[C@@H](C)O[C@@H]1CC(=O)O[C@H]31
InChIInChI=1S/C20H22O7/c1-9-14-16(19-12(26-9)8-13(21)27-19)17(23-3)10-6-7-11(22-2)18(24-4)15(10)20(14)25-5/h6-7,9,12,19H,8H2,1-5H3/t9-,12-,19+/m1/s1
InChIKeyREMXYFUORROQDG-VVSLUIPWSA-N
XLogP3.32
TPSA72.45 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds4
Heavy Atoms27
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500374.39
LogP ≤ 53.32
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze (11R,15R,17R)-2,4,5,9-tetramethoxy-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1,3(8),4,6,9-pentaen-13-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (11R,15R,17R)-2,4,5,9-tetramethoxy-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1,3(8),4,6,9-pentaen-13-one?
The IUPAC name of (11R,15R,17R)-2,4,5,9-tetramethoxy-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1,3(8),4,6,9-pentaen-13-one (CID 56590221) is (11R,15R,17R)-2,4,5,9-tetramethoxy-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1,3(8),4,6,9-pentaen-13-one.
What is the SMILES notation for (11R,15R,17R)-2,4,5,9-tetramethoxy-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1,3(8),4,6,9-pentaen-13-one?
The canonical SMILES for (11R,15R,17R)-2,4,5,9-tetramethoxy-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1,3(8),4,6,9-pentaen-13-one is COc1ccc2c(OC)c3c(c(OC)c2c1OC)[C@@H](C)O[C@@H]1CC(=O)O[C@H]31.
What is the InChIKey of (11R,15R,17R)-2,4,5,9-tetramethoxy-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1,3(8),4,6,9-pentaen-13-one?
The InChIKey is REMXYFUORROQDG-VVSLUIPWSA-N. The full InChI is InChI=1S/C20H22O7/c1-9-14-16(19-12(26-9)8-13(21)27-19)17(23-3)10-6-7-11(22-2)18(24-4)15(10)20(14)25-5/h6-7,9,12,19H,8H2,1-5H3/t9-,12-,19+/m1/s1.
What are the key properties of (11R,15R,17R)-2,4,5,9-tetramethoxy-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1,3(8),4,6,9-pentaen-13-one?
(11R,15R,17R)-2,4,5,9-tetramethoxy-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1,3(8),4,6,9-pentaen-13-one has a molecular weight of 374.39 g/mol, XLogP of 3.32, 4 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (11R,15R,17R)-2,4,5,9-tetramethoxy-17-methyl-12,16-dioxatetracyclo[8.7.0.03,8.011,15]heptadeca-1,3(8),4,6,9-pentaen-13-one is sourced from PubChem (CID 56590221), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).